Shanghai Kindly Medical Instruments Co., Ltd.

HKEX:1501.HK

28.4 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Revenue 413.072339.764360.666225.217284.062180.613186.584171.844151.388135.06971.61450.76550.76550.76534.38834.38834.38826.61126.61126.611
Cost of Revenue 175.352139.414152.203101.194124.25364.67765.99158.02259.91752.09828.00421.16621.16621.16614.93914.93914.93911.8611.8611.86
Gross Profit 237.72200.35208.463124.023159.809115.936120.593113.82291.47182.97143.61129.59929.59929.59919.44919.44919.44914.75114.75114.751
Gross Profit Ratio 0.5750.590.5780.5510.5630.6420.6460.6620.6040.6140.6090.5830.5830.5830.5660.5660.5660.5540.5540.554
Reseach & Development Expenses 61.25764.59361.70437.9344.89445.06134.37230.22118.11412.657.6915.5255.5255.5253.2313.2313.2312.7192.7192.719
General & Administrative Expenses 63.03736.38935.89728.39228.35120.716.88419.08222.87211.3038.5445.1265.1265.1262.8722.8722.8722.6192.6192.619
Selling & Marketing Expenses 34.37533.02134.6721.72416.60113.4198.71812.75713.910.0595.994.44.44.42.1512.1512.1511.5241.5241.524
SG&A 98.368.92970.85550.75345.48934.14925.60231.83936.7121.40314.5349.5269.5269.5265.0235.0235.0234.1434.1434.143
Other Expenses 000000000-1.16-1.16-14.992-14.992-14.992-0.591-0.591-0.591-0.593-0.593-0.593
Operating Expenses 154.573117.006128.12372.48572.26661.6868.77452.55942.39928.25521.0650.0590.0590.0597.6637.6637.6636.2696.2696.269
Operating Income 89.32274.74790.74938.59388.35456.28564.07461.27642.76150.90922.54616.21416.21416.21411.78611.78611.7868.4828.4828.482
Operating Income Ratio 0.2160.220.2520.1710.3110.3120.3430.3570.2820.3770.3150.3190.3190.3190.3430.3430.3430.3190.3190.319
Total Other Income Expenses Net -2.61113.67-3.1118.2367.4733.579-3.50815.24314.9053.3385.4330.4050.4050.4050.1460.1460.1461.3561.3561.356
Income Before Tax 86.71188.41787.63956.82995.82759.86460.56676.51957.66654.24727.97816.61816.61816.61811.93211.93211.9329.8389.8389.838
Income Before Tax Ratio 0.210.260.2430.2520.3370.3310.3250.4450.3810.4020.3910.3270.3270.3270.3470.3470.3470.370.370.37
Income Tax Expense 13.9887.9123.9316.7046.6768.578.7511.8187.4837.8953.8452.0592.0592.0591.741.741.741.3381.3381.338
Net Income 71.3880.50279.30450.84192.35550.60553.96167.39352.34847.26624.90414.61314.61314.61310.19310.19310.1938.58.58.5
Net Income Ratio 0.1730.2370.220.2260.3250.280.2890.3920.3460.350.3480.2880.2880.2880.2960.2960.2960.3190.3190.319
EPS 0.440.470.480.30.560.30.320.410.390.390.20.0910.0910.0910.0640.0640.0640.0530.0530.053
EPS Diluted 0.410.470.460.30.550.30.330.410.390.390.20.0910.0910.0910.0640.0640.0640.0530.0530.053
EBITDA 113.1493.722106.82353.166101.31167.49473.35369.88150.58854.79533.86519.7919.7919.7913.71713.71713.71711.34711.34711.347
EBITDA Ratio 0.2740.2760.2960.2360.3570.3740.3930.4070.3340.4060.4730.390.390.390.3990.3990.3990.4260.4260.426